Company Filing History:
Years Active: 1998
Title: The Innovations of Birgit-Christine Scholl
Introduction
Birgit-Christine Scholl is a notable inventor based in Uttenreuth, Germany. She has made significant contributions to the field of biotechnology, particularly in the study of human cytomegalovirus. With a total of 2 patents, her work has implications for vaccine development and diagnostic reagents.
Latest Patents
Scholl's latest patents include the structural phosphoprotein (PP150) of human cytomegalovirus. This phosphorylated structural protein, with a molecular weight of about 150 kDa, is highly immunogenic and is reliably recognized by human antisera. The protein can be prepared, in whole or in immunogenic sections, through gene manipulation after the assignment and sequencing of the gene. Such proteins are suitable as reagents, for example, in an ELISA, and as constituents of vaccines. Another patent focuses on the peptide of the structural phosphoprotein (PP150) of human cytomegalovirus, emphasizing its immunogenic properties and potential applications in vaccine development.
Career Highlights
Throughout her career, Scholl has worked with prominent companies in the biotechnology sector, including Behring Diagnostics GmbH. Her expertise in the field has allowed her to contribute to significant advancements in viral research and immunology.
Collaborations
Some of her notable coworkers include Gerhard Jahn and Michael Broker, who have collaborated with her on various projects related to her patents and research.
Conclusion
Birgit-Christine Scholl's innovative work in the field of biotechnology highlights her contributions to understanding human cytomegalovirus and developing potential vaccines. Her patents reflect her commitment to advancing medical science and improving public health.